Skip to main content

A new study identifies early signs of brain illness during sleep.


In a new study published in the journal eBioMedicine, researchers discovered a possible early warning sign for serious brain disorders like Parkinson's disease and Lewy body dementia.


The key resides in our sleep and the DNA found within our cells' powerhouses, the mitochondria.

Mitochondria play an important role in neuron survival, acting as tiny internal batteries for our brain cells. Unlike the majority of our body's cells, neurons rely almost entirely on these organelles for energy.

The study found that when mitochondrial DNA within these organelles begins to lose portions of its genetic code, it may warn the onset of neurodegenerative disorders long before the traditional symptoms occur.

The analysis was led by Álex Iranzo, a professor at the University of Barcelona and head of the Neurology Service at the Hospital Clinic of Barcelona, and Ramon Trullàs, a researcher from the Spanish National Research Council.


This study, led by Margalida Puigròs and colleagues, aimed to uncover the underlying causes of idiopathic REM sleep behaviour disorder (iRBD).

iRBD is a condition that interrupts the deepest stage of sleep, causing patients to play out their dreams, sometimes violently. This condition is noteworthy since it frequently precedes the onset of Parkinson's disease and Lewy body dementia.

To go deeper, the researchers examined cerebral fluid samples from 71 patients, some of whom had iRBD and others who developed Parkinson's disease or Lewy body dementia. Their findings were shocking.

Patients with iRBD had a higher level of mitochondrial DNA deletions—missing portions of genetic material—than those in a healthy control group.

The link between mitochondrial DNA damage and iRBD could be a key hint in understanding how neurodegenerative disorders develop.

What's more intriguing is that the amount of mitochondrial DNA with deletions in people with iRBD was associated to how rapidly they developed full-blown Parkinson's symptoms.

This finding shows that mitochondrial DNA damage is more than a side effect; it could be one of the first dominoes to fall in the complicated sequence of events that leads to these severe illnesses.

This discovery is a huge step forward in the fight against neurodegenerative disorders, providing hope for earlier detection and potentially leading to novel treatments.

Identifying early signals of disease before characteristic symptoms appear could allow clinicians to treat sooner, perhaps slowing or even halting the progression of disorders such as Parkinson's disease and Lewy body dementia.

The researchers ask for more research to determine the specific significance of mitochondrial DNA deletions in neurodegenerative diseases.

However, this study reveals a crucial insight: often the simplest details, particularly, shockingly, sleep habits, hold the key to solving the most complex mysteries in brain health.

If you are concerned about your brain's health, please read about research that link Vitamin B9 deficiency to an increased risk of dementia, and how cranberries may aid improve memory.

For additional information on brain health, please check new studies on heartburn medicines that may raise the risk of dementia, as well as findings indicating that the MIND diet may maintain cognitive function and prevent dementia.

The research results can be found at eBioMedicine.

Comments

Popular posts from this blog

Cutting calories may reduce cellular ageing and increase lifetime.

State College, Pennsylvania — Penn State researchers are presenting fresh persuasive data linking diets to ageing. Their study focused on telomeres, the genetic "end caps" that protect our chromosomes, and how calorie restriction impacts them. The scientists studied data from a two-year trial of caloric restriction in humans and published their findings in the journal Ageing Cell. They discovered that those who restricted their calories lost telomeres at different rates than the control group. Despite this, both groups concluded the research with roughly identical telomere lengths. Previous research found that reducing calories by 20 to 60 percent resulted in prolonged life for a variety of species. When a person's cells split, some telomeres are lost as chromosomes are copied to a new cell. The cell's telomeres are then shortened in total. The telomere cap eventually disappears as cells divide. The genetic information on the chromosome becomes more vulnerable to de...

DUI without alcohol? A rare syndrome in the intestines may be the culprit.

  Imagine you are a police officer. You see a car swerving all over the road. You pull over the driver, and they are plainly inebriated. They insist, with slurred speech, that they haven't consumed any alcohol all day. Do you believe them? In 2024, a Belgian man was acquitted after being arrested three times for DUI in four years. Though his position at a brewery raised suspicions, he asserted that he had not been drinking. Three doctors confirmed that he had auto-brewery syndrome and was ignorant. People with this illness have microorganisms in their intestines that produce abnormally high levels of alcohol when they break down sugars and carbs. Though it is an uncommon condition, a lady was acquitted of a DUI conviction in 2016 after being diagnosed with the same syndrome. Her blood alcohol level was four times the legal limit. I am a microbiologist who is fascinated by how the gut microbiome influences human health. As the author of the book "Pleased to Meet Me: Genes, G...

A study reveals serious side effects from common dementia medications.

Several antipsychotic medications used to treat dementia patients have been linked to dangerous side effects such as heart failure, according to a study released Thursday. A study published in the British Medical Journal (BMJ) found that using antipsychotics in persons with dementia can lead to major adverse outcomes such as stroke, blood clots, heart attack, heart failure, fracture, pneumonia, and acute kidney injury. Scientists discovered that the greatest hazards arise when therapy begins, "underscoring the need for increased caution in the early stages of treatment". Risperidone, quetiapine, haloperidol, and olanzapine are common antipsychotic medications used to treat psychotic illnesses such as schizophrenia. They are also used to treat depression that has proven resistant to other drugs, as well as those suffering from dementia, such as Alzheimer's disease. Antipsychotics are not designed to heal these conditions, but rather to alleviate certain symptoms such ...